Clinical Trial Update: Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating obeticholic acid in combination with ursodeoxycholic acid for primary biliary cirrhosis is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• Obeticholic acid (obeticholic acid)
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: UNKNOWN